nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP3A4—type 2 diabetes mellitus	0.194	1	CbGaD
Etravirine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0285	0.0511	CbGbCtD
Etravirine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0268	0.048	CbGbCtD
Etravirine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0262	0.047	CbGbCtD
Etravirine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0254	0.0456	CbGbCtD
Etravirine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.024	0.0429	CbGbCtD
Etravirine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0228	0.0408	CbGbCtD
Etravirine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0228	0.0408	CbGbCtD
Etravirine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0223	0.0399	CbGbCtD
Etravirine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.021	0.0377	CbGbCtD
Etravirine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0203	0.0364	CbGbCtD
Etravirine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0189	0.034	CbGbCtD
Etravirine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0189	0.034	CbGbCtD
Etravirine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0184	0.0329	CbGbCtD
Etravirine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0175	0.0313	CbGbCtD
Etravirine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0171	0.0306	CbGbCtD
Etravirine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0169	0.0303	CbGbCtD
Etravirine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0154	0.0277	CbGbCtD
Etravirine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0152	0.0273	CbGbCtD
Etravirine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0144	0.0257	CbGbCtD
Etravirine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0139	0.025	CbGbCtD
Etravirine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0138	0.0247	CbGbCtD
Etravirine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0126	0.0226	CbGbCtD
Etravirine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0122	0.0218	CbGbCtD
Etravirine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0117	0.0209	CbGbCtD
Etravirine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.011	0.0197	CbGbCtD
Etravirine—CYP2C19—Losartan—type 2 diabetes mellitus	0.0107	0.0191	CbGbCtD
Etravirine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00969	0.0174	CbGbCtD
Etravirine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00941	0.0169	CbGbCtD
Etravirine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00887	0.0159	CbGbCtD
Etravirine—ABCB1—Losartan—type 2 diabetes mellitus	0.0086	0.0154	CbGbCtD
Etravirine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00835	0.015	CbGbCtD
Etravirine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.008	0.0143	CbGbCtD
Etravirine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.008	0.0143	CbGbCtD
Etravirine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00757	0.0136	CbGbCtD
Etravirine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00564	0.0101	CbGbCtD
Etravirine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00516	0.00924	CbGbCtD
Etravirine—Rilpivirine—CYP1A2—type 2 diabetes mellitus	0.0013	0.602	CrCbGaD
Etravirine—Rilpivirine—CYP3A4—type 2 diabetes mellitus	0.000863	0.398	CrCbGaD
Etravirine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000121	0.000691	CcSEcCtD
Etravirine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000121	0.00069	CcSEcCtD
Etravirine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000121	0.000689	CcSEcCtD
Etravirine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000121	0.000689	CcSEcCtD
Etravirine—Flatulence—Losartan—type 2 diabetes mellitus	0.000121	0.000688	CcSEcCtD
Etravirine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000121	0.000688	CcSEcCtD
Etravirine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00012	0.000686	CcSEcCtD
Etravirine—Tension—Losartan—type 2 diabetes mellitus	0.00012	0.000685	CcSEcCtD
Etravirine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00012	0.000685	CcSEcCtD
Etravirine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00012	0.000685	CcSEcCtD
Etravirine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00012	0.000683	CcSEcCtD
Etravirine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00012	0.000683	CcSEcCtD
Etravirine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000119	0.000682	CcSEcCtD
Etravirine—Hypertension—Metformin—type 2 diabetes mellitus	0.000119	0.000679	CcSEcCtD
Etravirine—Nervousness—Losartan—type 2 diabetes mellitus	0.000119	0.000678	CcSEcCtD
Etravirine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000119	0.000678	CcSEcCtD
Etravirine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000118	0.000676	CcSEcCtD
Etravirine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000118	0.000676	CcSEcCtD
Etravirine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000118	0.000675	CcSEcCtD
Etravirine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000118	0.000673	CcSEcCtD
Etravirine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000118	0.000672	CcSEcCtD
Etravirine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000117	0.00067	CcSEcCtD
Etravirine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000117	0.000669	CcSEcCtD
Etravirine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000117	0.000667	CcSEcCtD
Etravirine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000117	0.000666	CcSEcCtD
Etravirine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000117	0.000665	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000116	0.000665	CcSEcCtD
Etravirine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000116	0.000662	CcSEcCtD
Etravirine—Discomfort—Metformin—type 2 diabetes mellitus	0.000116	0.000661	CcSEcCtD
Etravirine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000116	0.000661	CcSEcCtD
Etravirine—Nausea—Glipizide—type 2 diabetes mellitus	0.000115	0.000659	CcSEcCtD
Etravirine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000115	0.000659	CcSEcCtD
Etravirine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000115	0.000658	CcSEcCtD
Etravirine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000656	CcSEcCtD
Etravirine—Pain—Gliclazide—type 2 diabetes mellitus	0.000115	0.000656	CcSEcCtD
Etravirine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000115	0.000656	CcSEcCtD
Etravirine—Tremor—Losartan—type 2 diabetes mellitus	0.000115	0.000654	CcSEcCtD
Etravirine—Rash—Glimepiride—type 2 diabetes mellitus	0.000114	0.000653	CcSEcCtD
Etravirine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000114	0.000652	CcSEcCtD
Etravirine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000114	0.000652	CcSEcCtD
Etravirine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000651	CcSEcCtD
Etravirine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00065	CcSEcCtD
Etravirine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000114	0.00065	CcSEcCtD
Etravirine—Headache—Glimepiride—type 2 diabetes mellitus	0.000114	0.000649	CcSEcCtD
Etravirine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000114	0.000648	CcSEcCtD
Etravirine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000113	0.000647	CcSEcCtD
Etravirine—Anaemia—Losartan—type 2 diabetes mellitus	0.000113	0.000645	CcSEcCtD
Etravirine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000112	0.000641	CcSEcCtD
Etravirine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000639	CcSEcCtD
Etravirine—Angioedema—Losartan—type 2 diabetes mellitus	0.000112	0.000638	CcSEcCtD
Etravirine—Infection—Metformin—type 2 diabetes mellitus	0.000112	0.000638	CcSEcCtD
Etravirine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000112	0.000637	CcSEcCtD
Etravirine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000111	0.000633	CcSEcCtD
Etravirine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000111	0.000632	CcSEcCtD
Etravirine—Shock—Metformin—type 2 diabetes mellitus	0.000111	0.000631	CcSEcCtD
Etravirine—Insomnia—Orlistat—type 2 diabetes mellitus	0.00011	0.00063	CcSEcCtD
Etravirine—Malaise—Losartan—type 2 diabetes mellitus	0.00011	0.00063	CcSEcCtD
Etravirine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00011	0.00063	CcSEcCtD
Etravirine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00011	0.000629	CcSEcCtD
Etravirine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00011	0.000629	CcSEcCtD
Etravirine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00011	0.000628	CcSEcCtD
Etravirine—Vertigo—Losartan—type 2 diabetes mellitus	0.00011	0.000627	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00011	0.000627	CcSEcCtD
Etravirine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00011	0.000627	CcSEcCtD
Etravirine—Somnolence—Valsartan—type 2 diabetes mellitus	0.00011	0.000627	CcSEcCtD
Etravirine—Syncope—Losartan—type 2 diabetes mellitus	0.00011	0.000626	CcSEcCtD
Etravirine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00011	0.000625	CcSEcCtD
Etravirine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000109	0.000624	CcSEcCtD
Etravirine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000109	0.000623	CcSEcCtD
Etravirine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000621	CcSEcCtD
Etravirine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000109	0.00062	CcSEcCtD
Etravirine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.00062	CcSEcCtD
Etravirine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000108	0.000618	CcSEcCtD
Etravirine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000108	0.000618	CcSEcCtD
Etravirine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000108	0.000615	CcSEcCtD
Etravirine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000108	0.000614	CcSEcCtD
Etravirine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000107	0.000613	CcSEcCtD
Etravirine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000107	0.000613	CcSEcCtD
Etravirine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000107	0.000613	CcSEcCtD
Etravirine—Anorexia—Metformin—type 2 diabetes mellitus	0.000107	0.000612	CcSEcCtD
Etravirine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000107	0.000608	CcSEcCtD
Etravirine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000106	0.000608	CcSEcCtD
Etravirine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000106	0.000606	CcSEcCtD
Etravirine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000106	0.000606	CcSEcCtD
Etravirine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000106	0.000605	CcSEcCtD
Etravirine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000106	0.000603	CcSEcCtD
Etravirine—Constipation—Valsartan—type 2 diabetes mellitus	0.000106	0.000603	CcSEcCtD
Etravirine—Infection—Irbesartan—type 2 diabetes mellitus	0.000105	0.000602	CcSEcCtD
Etravirine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000105	0.000601	CcSEcCtD
Etravirine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000105	0.0006	CcSEcCtD
Etravirine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000105	0.000599	CcSEcCtD
Etravirine—Shock—Irbesartan—type 2 diabetes mellitus	0.000104	0.000596	CcSEcCtD
Etravirine—Pain—Orlistat—type 2 diabetes mellitus	0.000104	0.000595	CcSEcCtD
Etravirine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000594	CcSEcCtD
Etravirine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.000594	CcSEcCtD
Etravirine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000104	0.000593	CcSEcCtD
Etravirine—Anxiety—Losartan—type 2 diabetes mellitus	0.000104	0.000592	CcSEcCtD
Etravirine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000589	CcSEcCtD
Etravirine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000589	CcSEcCtD
Etravirine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000103	0.000588	CcSEcCtD
Etravirine—Tension—Ramipril—type 2 diabetes mellitus	0.000103	0.000588	CcSEcCtD
Etravirine—Discomfort—Losartan—type 2 diabetes mellitus	0.000103	0.000587	CcSEcCtD
Etravirine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000103	0.000585	CcSEcCtD
Etravirine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000585	CcSEcCtD
Etravirine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000102	0.000584	CcSEcCtD
Etravirine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000102	0.000582	CcSEcCtD
Etravirine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000102	0.000581	CcSEcCtD
Etravirine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000101	0.000577	CcSEcCtD
Etravirine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000101	0.000576	CcSEcCtD
Etravirine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000101	0.000576	CcSEcCtD
Etravirine—Confusional state—Losartan—type 2 diabetes mellitus	0.000101	0.000575	CcSEcCtD
Etravirine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000101	0.000574	CcSEcCtD
Etravirine—Somnolence—Metformin—type 2 diabetes mellitus	9.99e-05	0.000571	CcSEcCtD
Etravirine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.98e-05	0.000569	CcSEcCtD
Etravirine—Infection—Losartan—type 2 diabetes mellitus	9.92e-05	0.000566	CcSEcCtD
Etravirine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.9e-05	0.000565	CcSEcCtD
Etravirine—Tremor—Ramipril—type 2 diabetes mellitus	9.83e-05	0.000561	CcSEcCtD
Etravirine—Shock—Losartan—type 2 diabetes mellitus	9.82e-05	0.000561	CcSEcCtD
Etravirine—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.79e-05	0.000559	CcSEcCtD
Etravirine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.78e-05	0.000558	CcSEcCtD
Etravirine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.77e-05	0.000558	CcSEcCtD
Etravirine—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.76e-05	0.000557	CcSEcCtD
Etravirine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000556	CcSEcCtD
Etravirine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.72e-05	0.000555	CcSEcCtD
Etravirine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.71e-05	0.000554	CcSEcCtD
Etravirine—Fatigue—Metformin—type 2 diabetes mellitus	9.69e-05	0.000553	CcSEcCtD
Etravirine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.65e-05	0.000551	CcSEcCtD
Etravirine—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.64e-05	0.00055	CcSEcCtD
Etravirine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.64e-05	0.00055	CcSEcCtD
Etravirine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.64e-05	0.00055	CcSEcCtD
Etravirine—Constipation—Metformin—type 2 diabetes mellitus	9.61e-05	0.000549	CcSEcCtD
Etravirine—Angioedema—Ramipril—type 2 diabetes mellitus	9.59e-05	0.000547	CcSEcCtD
Etravirine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.53e-05	0.000544	CcSEcCtD
Etravirine—Anorexia—Losartan—type 2 diabetes mellitus	9.52e-05	0.000543	CcSEcCtD
Etravirine—Vomiting—Glyburide—type 2 diabetes mellitus	9.51e-05	0.000543	CcSEcCtD
Etravirine—Malaise—Ramipril—type 2 diabetes mellitus	9.46e-05	0.00054	CcSEcCtD
Etravirine—Rash—Glyburide—type 2 diabetes mellitus	9.44e-05	0.000539	CcSEcCtD
Etravirine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000538	CcSEcCtD
Etravirine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.43e-05	0.000538	CcSEcCtD
Etravirine—Vertigo—Ramipril—type 2 diabetes mellitus	9.42e-05	0.000538	CcSEcCtD
Etravirine—Syncope—Ramipril—type 2 diabetes mellitus	9.41e-05	0.000537	CcSEcCtD
Etravirine—Headache—Glyburide—type 2 diabetes mellitus	9.37e-05	0.000535	CcSEcCtD
Etravirine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.26e-05	0.000529	CcSEcCtD
Etravirine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000526	CcSEcCtD
Etravirine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.22e-05	0.000526	CcSEcCtD
Etravirine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.19e-05	0.000525	CcSEcCtD
Etravirine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.19e-05	0.000525	CcSEcCtD
Etravirine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000523	CcSEcCtD
Etravirine—Fatigue—Irbesartan—type 2 diabetes mellitus	9.15e-05	0.000522	CcSEcCtD
Etravirine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.1e-05	0.000519	CcSEcCtD
Etravirine—Convulsion—Ramipril—type 2 diabetes mellitus	9.09e-05	0.000519	CcSEcCtD
Etravirine—Pain—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000518	CcSEcCtD
Etravirine—Constipation—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000518	CcSEcCtD
Etravirine—Insomnia—Losartan—type 2 diabetes mellitus	9.03e-05	0.000515	CcSEcCtD
Etravirine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.99e-05	0.000513	CcSEcCtD
Etravirine—Paraesthesia—Losartan—type 2 diabetes mellitus	8.97e-05	0.000512	CcSEcCtD
Etravirine—Anxiety—Ramipril—type 2 diabetes mellitus	8.9e-05	0.000508	CcSEcCtD
Etravirine—Nausea—Glyburide—type 2 diabetes mellitus	8.89e-05	0.000507	CcSEcCtD
Etravirine—Abdominal pain—Metformin—type 2 diabetes mellitus	8.89e-05	0.000507	CcSEcCtD
Etravirine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.89e-05	0.000507	CcSEcCtD
Etravirine—Somnolence—Losartan—type 2 diabetes mellitus	8.88e-05	0.000507	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000506	CcSEcCtD
Etravirine—Asthenia—Valsartan—type 2 diabetes mellitus	8.86e-05	0.000506	CcSEcCtD
Etravirine—Discomfort—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000504	CcSEcCtD
Etravirine—Asthenia—Orlistat—type 2 diabetes mellitus	8.75e-05	0.0005	CcSEcCtD
Etravirine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000499	CcSEcCtD
Etravirine—Dry mouth—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000499	CcSEcCtD
Etravirine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.68e-05	0.000495	CcSEcCtD
Etravirine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.68e-05	0.000495	CcSEcCtD
Etravirine—Confusional state—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000493	CcSEcCtD
Etravirine—Fatigue—Losartan—type 2 diabetes mellitus	8.61e-05	0.000491	CcSEcCtD
Etravirine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.54e-05	0.000488	CcSEcCtD
Etravirine—Pain—Losartan—type 2 diabetes mellitus	8.54e-05	0.000487	CcSEcCtD
Etravirine—Constipation—Losartan—type 2 diabetes mellitus	8.54e-05	0.000487	CcSEcCtD
Etravirine—Rash—Gliclazide—type 2 diabetes mellitus	8.47e-05	0.000484	CcSEcCtD
Etravirine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.46e-05	0.000483	CcSEcCtD
Etravirine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.45e-05	0.000482	CcSEcCtD
Etravirine—Shock—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000481	CcSEcCtD
Etravirine—Headache—Gliclazide—type 2 diabetes mellitus	8.42e-05	0.000481	CcSEcCtD
Etravirine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000479	CcSEcCtD
Etravirine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.000479	CcSEcCtD
Etravirine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.000479	CcSEcCtD
Etravirine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000479	CcSEcCtD
Etravirine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.35e-05	0.000476	CcSEcCtD
Etravirine—Skin disorder—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000475	CcSEcCtD
Etravirine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000472	CcSEcCtD
Etravirine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.23e-05	0.00047	CcSEcCtD
Etravirine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.16e-05	0.000466	CcSEcCtD
Etravirine—Dizziness—Valsartan—type 2 diabetes mellitus	8.16e-05	0.000466	CcSEcCtD
Etravirine—Anorexia—Ramipril—type 2 diabetes mellitus	8.16e-05	0.000466	CcSEcCtD
Etravirine—Dizziness—Orlistat—type 2 diabetes mellitus	8.07e-05	0.00046	CcSEcCtD
Etravirine—Asthenia—Metformin—type 2 diabetes mellitus	8.07e-05	0.00046	CcSEcCtD
Etravirine—Nausea—Gliclazide—type 2 diabetes mellitus	7.98e-05	0.000456	CcSEcCtD
Etravirine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.89e-05	0.000451	CcSEcCtD
Etravirine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.89e-05	0.000451	CcSEcCtD
Etravirine—Vomiting—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000448	CcSEcCtD
Etravirine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.82e-05	0.000446	CcSEcCtD
Etravirine—Rash—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000444	CcSEcCtD
Etravirine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000444	CcSEcCtD
Etravirine—Vomiting—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000443	CcSEcCtD
Etravirine—Insomnia—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000442	CcSEcCtD
Etravirine—Headache—Valsartan—type 2 diabetes mellitus	7.73e-05	0.000441	CcSEcCtD
Etravirine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.69e-05	0.000439	CcSEcCtD
Etravirine—Rash—Orlistat—type 2 diabetes mellitus	7.69e-05	0.000439	CcSEcCtD
Etravirine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000439	CcSEcCtD
Etravirine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000439	CcSEcCtD
Etravirine—Headache—Orlistat—type 2 diabetes mellitus	7.64e-05	0.000436	CcSEcCtD
Etravirine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.000435	CcSEcCtD
Etravirine—Somnolence—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000434	CcSEcCtD
Etravirine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000425	CcSEcCtD
Etravirine—Dizziness—Metformin—type 2 diabetes mellitus	7.43e-05	0.000424	CcSEcCtD
Etravirine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000422	CcSEcCtD
Etravirine—Fatigue—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000421	CcSEcCtD
Etravirine—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.36e-05	0.00042	CcSEcCtD
Etravirine—Nausea—Valsartan—type 2 diabetes mellitus	7.33e-05	0.000419	CcSEcCtD
Etravirine—Constipation—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000418	CcSEcCtD
Etravirine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000414	CcSEcCtD
Etravirine—Nausea—Orlistat—type 2 diabetes mellitus	7.25e-05	0.000414	CcSEcCtD
Etravirine—Asthenia—Losartan—type 2 diabetes mellitus	7.16e-05	0.000409	CcSEcCtD
Etravirine—Vomiting—Metformin—type 2 diabetes mellitus	7.15e-05	0.000408	CcSEcCtD
Etravirine—Rash—Metformin—type 2 diabetes mellitus	7.09e-05	0.000405	CcSEcCtD
Etravirine—Dermatitis—Metformin—type 2 diabetes mellitus	7.08e-05	0.000404	CcSEcCtD
Etravirine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000403	CcSEcCtD
Etravirine—Headache—Metformin—type 2 diabetes mellitus	7.04e-05	0.000402	CcSEcCtD
Etravirine—Dizziness—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.0004	CcSEcCtD
Etravirine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7e-05	0.0004	CcSEcCtD
Etravirine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.83e-05	0.00039	CcSEcCtD
Etravirine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000386	CcSEcCtD
Etravirine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000386	CcSEcCtD
Etravirine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000385	CcSEcCtD
Etravirine—Rash—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000382	CcSEcCtD
Etravirine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000382	CcSEcCtD
Etravirine—Nausea—Metformin—type 2 diabetes mellitus	6.68e-05	0.000381	CcSEcCtD
Etravirine—Headache—Irbesartan—type 2 diabetes mellitus	6.65e-05	0.000379	CcSEcCtD
Etravirine—Dizziness—Losartan—type 2 diabetes mellitus	6.6e-05	0.000377	CcSEcCtD
Etravirine—Vomiting—Losartan—type 2 diabetes mellitus	6.35e-05	0.000362	CcSEcCtD
Etravirine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.31e-05	0.00036	CcSEcCtD
Etravirine—Nausea—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.00036	CcSEcCtD
Etravirine—Rash—Losartan—type 2 diabetes mellitus	6.3e-05	0.000359	CcSEcCtD
Etravirine—Dermatitis—Losartan—type 2 diabetes mellitus	6.29e-05	0.000359	CcSEcCtD
Etravirine—Headache—Losartan—type 2 diabetes mellitus	6.25e-05	0.000357	CcSEcCtD
Etravirine—Asthenia—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000351	CcSEcCtD
Etravirine—Nausea—Losartan—type 2 diabetes mellitus	5.93e-05	0.000339	CcSEcCtD
Etravirine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000334	CcSEcCtD
Etravirine—Dizziness—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000323	CcSEcCtD
Etravirine—Vomiting—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000311	CcSEcCtD
Etravirine—Rash—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000308	CcSEcCtD
Etravirine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000308	CcSEcCtD
Etravirine—Headache—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000306	CcSEcCtD
Etravirine—Nausea—Ramipril—type 2 diabetes mellitus	5.09e-05	0.00029	CcSEcCtD
Etravirine—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.08e-05	0.000154	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.08e-05	0.000154	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.08e-05	0.000154	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.08e-05	0.000154	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.08e-05	0.000153	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.07e-05	0.000152	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.07e-05	0.000152	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.07e-05	0.000151	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	1.06e-05	0.000151	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.05e-05	0.000149	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.05e-05	0.000149	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.03e-05	0.000147	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.01e-05	0.000144	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.01e-05	0.000144	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.01e-05	0.000144	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.01e-05	0.000144	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.01e-05	0.000144	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1e-05	0.000142	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1e-05	0.000142	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.91e-06	0.000141	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	9.9e-06	0.00014	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.74e-06	0.000138	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	9.71e-06	0.000138	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	9.66e-06	0.000137	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	9.48e-06	0.000134	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	9.48e-06	0.000134	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.43e-06	0.000134	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.3e-06	0.000132	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	9.24e-06	0.000131	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.24e-06	0.000131	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.24e-06	0.000131	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.13e-06	0.00013	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	9.05e-06	0.000128	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	9.05e-06	0.000128	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	9.03e-06	0.000128	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	9.02e-06	0.000128	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	8.88e-06	0.000126	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	8.84e-06	0.000125	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	8.84e-06	0.000125	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.83e-06	0.000125	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	8.82e-06	0.000125	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	8.82e-06	0.000125	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	8.82e-06	0.000125	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	8.81e-06	0.000125	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	8.81e-06	0.000125	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	8.81e-06	0.000125	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	8.77e-06	0.000124	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	8.67e-06	0.000123	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	8.61e-06	0.000122	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	8.61e-06	0.000122	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	8.61e-06	0.000122	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	8.61e-06	0.000122	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	8.56e-06	0.000121	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	8.51e-06	0.000121	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.45e-06	0.00012	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.45e-06	0.00012	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	8.43e-06	0.00012	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	8.4e-06	0.000119	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	8.31e-06	0.000118	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	8.25e-06	0.000117	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	8.25e-06	0.000117	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.16e-06	0.000116	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.13e-06	0.000115	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.13e-06	0.000115	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	8.1e-06	0.000115	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.05e-06	0.000114	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	8.04e-06	0.000114	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	8.04e-06	0.000114	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	8.04e-06	0.000114	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	7.99e-06	0.000113	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.99e-06	0.000113	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.94e-06	0.000113	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	7.91e-06	0.000112	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	7.91e-06	0.000112	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	7.91e-06	0.000112	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.85e-06	0.000111	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.85e-06	0.000111	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.85e-06	0.000111	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	7.85e-06	0.000111	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	7.77e-06	0.00011	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	7.76e-06	0.00011	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	7.72e-06	0.00011	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	7.72e-06	0.00011	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	7.72e-06	0.00011	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	7.7e-06	0.000109	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.59e-06	0.000108	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	7.58e-06	0.000108	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	7.53e-06	0.000107	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	7.51e-06	0.000107	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.38e-06	0.000105	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.37e-06	0.000104	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	7.35e-06	0.000104	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	7.24e-06	0.000103	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.24e-06	0.000103	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	7.22e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	7.22e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	7.22e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	7.16e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	7.16e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	7.08e-06	0.0001	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	7.06e-06	0.0001	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	7.02e-06	9.96e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.98e-06	9.91e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.98e-06	9.91e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	6.98e-06	9.9e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.94e-06	9.85e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.92e-06	9.82e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.91e-06	9.81e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	6.87e-06	9.74e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	6.86e-06	9.73e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	6.86e-06	9.73e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.81e-06	9.66e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	6.7e-06	9.5e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.7e-06	9.5e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.68e-06	9.47e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.68e-06	9.47e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.68e-06	9.47e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.68e-06	9.47e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	6.6e-06	9.36e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	6.53e-06	9.26e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	6.53e-06	9.26e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.4e-06	9.08e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	6.36e-06	9.03e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.33e-06	8.98e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	6.26e-06	8.87e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	6.26e-06	8.87e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.95e-06	8.44e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.91e-06	8.39e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	5.91e-06	8.39e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	5.89e-06	8.35e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	5.81e-06	8.24e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.77e-06	8.19e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	5.77e-06	8.19e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	5.75e-06	8.15e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5.67e-06	8.04e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	5.64e-06	8e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.56e-06	7.88e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	5.5e-06	7.81e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	5.48e-06	7.78e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.44e-06	7.72e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.44e-06	7.72e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.39e-06	7.65e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	5.39e-06	7.65e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	5.38e-06	7.64e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	5.37e-06	7.61e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.35e-06	7.59e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.34e-06	7.57e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.31e-06	7.53e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.31e-06	7.53e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.31e-06	7.53e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	5.3e-06	7.51e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.27e-06	7.48e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	5.27e-06	7.48e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	5.25e-06	7.45e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	5.25e-06	7.45e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.18e-06	7.35e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	5.14e-06	7.3e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	5.14e-06	7.29e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.13e-06	7.27e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.12e-06	7.26e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	5.12e-06	7.26e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	5.05e-06	7.17e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	5e-06	7.09e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.99e-06	7.08e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.93e-06	6.99e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.91e-06	6.96e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	4.85e-06	6.88e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.81e-06	6.82e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.79e-06	6.79e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.76e-06	6.75e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.76e-06	6.75e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.76e-06	6.75e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	4.76e-06	6.75e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.73e-06	6.71e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.67e-06	6.63e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.66e-06	6.62e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.64e-06	6.58e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.63e-06	6.57e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.61e-06	6.53e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	4.61e-06	6.53e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.53e-06	6.43e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	4.53e-06	6.42e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	4.51e-06	6.4e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.5e-06	6.38e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	4.46e-06	6.33e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.42e-06	6.27e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.42e-06	6.27e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.4e-06	6.25e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.35e-06	6.18e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.35e-06	6.17e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.34e-06	6.15e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.3e-06	6.1e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.3e-06	6.1e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	4.2e-06	5.96e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	4.13e-06	5.86e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.13e-06	5.85e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.13e-06	5.85e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	4.11e-06	5.84e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	4.07e-06	5.77e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.93e-06	5.58e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.86e-06	5.47e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.84e-06	5.44e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.76e-06	5.34e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.58e-06	5.08e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.56e-06	5.04e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.56e-06	5.04e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.54e-06	5.02e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.53e-06	5.01e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.52e-06	4.99e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.49e-06	4.95e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.45e-06	4.89e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.39e-06	4.81e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	3.38e-06	4.8e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	3.38e-06	4.8e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.3e-06	4.68e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.3e-06	4.68e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.3e-06	4.68e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.24e-06	4.59e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.22e-06	4.57e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.17e-06	4.5e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.16e-06	4.48e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	3.09e-06	4.39e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.08e-06	4.37e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.08e-06	4.37e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.08e-06	4.36e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.04e-06	4.31e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.02e-06	4.28e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.91e-06	4.13e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.86e-06	4.06e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.82e-06	4e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.77e-06	3.93e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.72e-06	3.86e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.71e-06	3.85e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.68e-06	3.81e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.36e-06	3.35e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.32e-06	3.29e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.13e-06	3.01e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.03e-06	2.88e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.03e-06	2.88e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.86e-06	2.64e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.55e-06	2.2e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.52e-06	2.15e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.42e-06	2.01e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.35e-07	1.33e-05	CbGpPWpGaD
